Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture.

MLA

Lyles, Kenneth W., et al. “Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture.” New England Journal of Medicine, vol. 357, no. 18, Nov. 2007, pp. 1799–809. EBSCOhost, https://doi.org/10.1056/NEJMoa074941.

APA

Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., Lavecchia, C., Zhang, J., Mesenbrink, P., Hodgson, P. K., Abrams, K., Orloff, J. J., Horowitz, Z., Eriksen, E. F., & Boonen, S. (2007). Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture. New England Journal of Medicine, 357(18), 1799–1809. https://doi.org/10.1056/NEJMoa074941

Chicago

Lyles, Kenneth W., Cathleen S. Colón-Emeric, Jay S. Magaziner, Jonathan D. Adachi, Carl F. Pieper, Carlos Mautalen, Lars Hyldstrup, et al. 2007. “Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture.” New England Journal of Medicine 357 (18): 1799–1809. doi:10.1056/NEJMoa074941.